文献速递前列腺癌

门诊MRI/US融合经会阴前列腺穿刺的临床应用评估

Evaluation of In-Office MRI/US Fusion Transperineal Prostate Biopsy via Free-hand Device during Routine Clinical Practice.
PubMed 文献 · Urology · 2021-05-25

本研究回顾性比较2018-2020年130例经会阴前列腺穿刺与2014-2018年130例经直肠融合穿刺(按年龄、PSA及既往前列腺癌诊断匹配)。结论:经会阴穿刺门诊可行且无感染并发症,非感染性并发症较高。

要点

  • 门诊经会阴前列腺穿刺可行,感染率为0%。
  • 经会阴组总并发症率6.1%,高于经直肠组的0.8%。
  • 软件辅助MRI/US融合可整合于经会阴穿刺靶向可疑病灶。

核心结论

  • 经会阴前列腺穿刺在门诊泌尿外科实践中可行,无感染并发症。
  • 软件辅助MRI/US融合技术可成功整合于经会阴穿刺以靶向可疑病灶。
  • 与经直肠穿刺相比,经会阴穿刺非感染性并发症发生率更高。

研究设计与样本

  • 单中心回顾性队列研究,经会阴穿刺组130例(2018-2020年),经直肠融合穿刺组130例(2014-2018年),按年龄、PSA及穿刺前前列腺癌诊断匹配。

主要发现

  • 经会阴组30%接受融合穿刺,经直肠组全部接受融合穿刺。
  • 经会阴组预防性抗生素使用48%,经直肠组100%。

关键数值与推荐

  • 所有患者均接受系统经会阴模板穿刺及MRI可见病灶的融合穿刺。

临床怎么用

  • 门诊可开展经会阴前列腺穿刺,感染风险低,可减少预防性抗生素使用。
  • 需关注非感染性并发症,尤其在开展初期。

局限性

  • 回顾性单中心设计,样本量有限。
  • 经会阴组仅30%接受融合穿刺,与经直肠组全部融合穿刺存在差异。
  • 需进一步分析学习曲线对风险谱的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe our recent experience with in-office transperineal prostate biopsy, including the adoption of software-assisted MRI/US fusion technology. Technological improvements have recently allowed transperineal biopsy to be effectively integrated into outpatient practices with negligible risk of infection. METHODS: We retrospectively reviewed a cohort of men undergoing transperineal prostate biopsy from 2018-2020, at a single institution. We compared this to another cohort of men undergoing transrectal fusion biopsy from 2014-2018, matched to the first cohort based on age, PSA, and presence of prostate cancer diagnosis prior to biopsy. All patients underwent systematic transperineal templated biopsies in addition to fusion biopsies of MRI-visible lesions. Baseline characteristics, MRI findings, biopsy results, and complications were analyzed and compared between the 2 groups. RESULTS: One-hundred and thirty men underwent transperineal prostate biopsy, and 130 men underwent transrectal fusion biopsy. Of those who underwent transperineal biopsy, 30% underwent fusion biopsy while all men with the transrectal biopsy underwent fusion biopsy. Men who underwent transperineal vs transrectal biopsy demonstrated lower infection rates (0% vs 0.8%, P = .31) with fewer prophylactic antibiotics prescribed at provider's discretion (48% vs 100%), yet higher total post-biopsy complication rates (6.1% vs 0.8%, P = .036). CONCLUSION: Our initial experiences with transperineal prostate biopsy confirm prior findings demonstrating feasibility in outpatient urologic practice without infectious complication. Software-assisted MRI/US fusion technology can be successfully integrated with transperineal biopsies to target suspicious lesions. Higher rates of non-infectious complications were observed compared with transrectal biopsy. Further analysis is needed to determine whether risk profiles improve over the learning curve of this newly implemented approach.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Briggs LG, Kim M, Gusev A, et al. Evaluation of In-Office MRI/US Fusion Transperineal Prostate Biopsy via Free-hand Device during Routine Clinical Practice. Urology. 2021. PMID: 34048827. doi:10.1016/j.urology.2021.04.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。